US Patent Issued to St. Jude Children's Research Hospital on Oct. 28 for "Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein" (Tennessee Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,518, issued on Oct. 28, was assigned to St. Jude Children's Research Hospital Inc. (Memphis, Tenn.).

"Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein" was invented by Marcus Fischer (Memphis, Tenn.), Fatemeh Keramatnia (Memphis, Tenn.), Kevin Mcgowan (Memphis, Tenn.), Jaeki Min (Memphis, Tenn.), Gisele A. Nishiguchi (Memphis, Tenn.), Jeanine Price (Memphis, Tenn.), Zoran Rankovic (Memphis, Tenn.), Sourav Das (Memphis, Tenn.), Charles G. Mullighan (Memphis, Tenn.) and Yunchao Chang (Memphis, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, the disclosure ...